Not news but the implications are points to ponder. Points to ponder: Health care costs continue to skyrocket. These drugs are expensive and provide marginal if any benefit. Only Big Pharma, and the institutions and doctors that provide the treatments benefit for sure. To the extent the drugs do work, a couple months or so … Continue reading Study: Most new cancer drugs of dubious therapeutic value
via JunkScience.com
October 4, 2017 at 06:31PM
Iowa Climate Science Education 